UPDATED Apr 23, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ATAKP | ₺46.08 | -2.2% | n/a | ₺6.4b | ₺67.66 | PE21.6x | E72.8% | n/a | Food, Beverage & Tobacco | ||
CALTX | kr100.40 | -0.1% | -22.2% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.72 | 3.2% | 101.0% | €133.7m | €12.75 | PE27.2x | E22.8% | n/a | Capital Goods | ||
TGTX | US$14.25 | 3.1% | -35.5% | US$2.2b | US$29.75 | PE173.8x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$146.07 | 0.5% | -26.0% | US$18.5b | US$220.00 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$22.60 | 2.9% | 25.6% | US$2.5b | US$25.50 | PE23.5x | E43.0% | 3.7% | Energy | ||
ZVRA | US$4.58 | -1.3% | -11.6% | US$191.7m | US$19.00 | PS7x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
ESTA | US$49.69 | -4.7% | -29.8% | US$1.4b | US$59.29 | PS8.3x | E65.4% | n/a | Healthcare | ||
ASND | US$144.83 | 1.9% | 89.5% | US$8.3b | US$177.45 | PS29x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.19 | -2.1% | 70.3% | US$218.7m | US$8.50 | PS2.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.55 | -8.0% | 28.2% | R$693.4m | R$9.90 | PS1.5x | E101.9% | n/a | Consumer Durables | ||
AXSM | US$73.08 | 4.8% | 4.2% | US$3.5b | US$121.13 | PS12.8x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$22.76 | 2.1% | 52.0% | R$3.9b | R$28.53 | PE11.9x | E25.1% | 2.1% | Consumer Durables | ||
PRL | CA$23.37 | 9.6% | 256.8% | CA$802.2m | CA$24.37 | PE21.1x | E33.6% | 2.0% | Diversified Financials | ||
EH | US$17.35 | 0.2% | 67.8% | US$1.1b | US$23.83 | PS67.7x | E97.6% | n/a | Capital Goods | ||
LKNC.Y | US$22.00 | -3.9% | -14.8% | US$6.2b | n/a | PE15.7x | E24.4% | n/a | Consumer Services | ||
ALKT | US$24.57 | 3.1% | 108.4% | US$2.4b | US$28.70 | PS9x | E80.1% | n/a | Software | ||
NVDA | US$824.23 | -1.9% | 205.8% | US$2.0t | US$992.48 | PE68.2x | E22.9% | 0.02% | Semiconductors | ||
A211050 | ₩4,900.00 | 0% | 140.0% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
CTT | AU$3.01 | -1.6% | 52.8% | AU$1.2b | AU$4.26 | PE59.3x | E29.9% | n/a | Retail | ||
RCEL | US$8.98 | -4.3% | -36.3% | US$231.7m | US$26.06 | PS4.6x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$176.99 | 6.5% | 88.6% | US$9.8b | US$206.21 | PE75.9x | E27.2% | n/a | Household | ||
HDG | ₫26,400.00 | 1.5% | 0.2% | ₫7.8t | ₫32,300.00 | PE12.1x | E31.4% | 0% | Capital Goods | ||
666 | HK$14.64 | 1.1% | n/a | HK$33.2b | HK$16.93 | PS2.2x | E97.0% | n/a | Capital Goods |